Knome Selected for Illumina Genome Network | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Knome announced today it has been selected to be a partner in the Illumina Genome Network.

As a result, customers in IGN will have access to preferential pricing for Knome's genome interpretation tools and services, the Cambridge, Mass.-based company said. Knome and Illumina will further integrate their data pipelines to accelerate turnaround times as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.